GO:0044822 | poly(A) RNA binding | 9.68e-05 | 1.00e+00 | 3.094 | 5 | 50 | 1056 |
GO:0008380 | RNA splicing | 2.06e-04 | 1.00e+00 | 4.568 | 3 | 22 | 228 |
GO:0000502 | proteasome complex | 4.38e-04 | 1.00e+00 | 5.958 | 2 | 3 | 58 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0035063 | nuclear speck organization | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0008193 | tRNA guanylyltransferase activity | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0060913 | cardiac cell fate determination | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0001714 | endodermal cell fate specification | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0050920 | regulation of chemotaxis | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0048024 | regulation of mRNA splicing, via spliceosome | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 6 |
GO:0016607 | nuclear speck | 3.78e-03 | 1.00e+00 | 4.390 | 2 | 12 | 172 |
GO:0045446 | endothelial cell differentiation | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 7 |
GO:0005737 | cytoplasm | 5.35e-03 | 1.00e+00 | 1.522 | 6 | 124 | 3767 |
GO:0035413 | positive regulation of catenin import into nucleus | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 2 | 10 |
GO:0070628 | proteasome binding | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 1 | 10 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 4 | 11 |
GO:0061136 | regulation of proteasomal protein catabolic process | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 12 |
GO:0005838 | proteasome regulatory particle | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 12 |
GO:0030234 | enzyme regulator activity | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 2 | 13 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 2 | 13 |
GO:0005685 | U1 snRNP | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 14 |
GO:0006376 | mRNA splice site selection | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 15 |
GO:0001824 | blastocyst development | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 2 | 15 |
GO:0019216 | regulation of lipid metabolic process | 8.84e-03 | 1.00e+00 | 6.816 | 1 | 1 | 16 |
GO:0043274 | phospholipase binding | 8.84e-03 | 1.00e+00 | 6.816 | 1 | 1 | 16 |
GO:0042176 | regulation of protein catabolic process | 8.84e-03 | 1.00e+00 | 6.816 | 1 | 2 | 16 |
GO:0022624 | proteasome accessory complex | 9.39e-03 | 1.00e+00 | 6.729 | 1 | 1 | 17 |
GO:0045070 | positive regulation of viral genome replication | 9.39e-03 | 1.00e+00 | 6.729 | 1 | 1 | 17 |
GO:0071889 | 14-3-3 protein binding | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 2 | 18 |
GO:0005515 | protein binding | 1.12e-02 | 1.00e+00 | 1.067 | 7 | 198 | 6024 |
GO:0000245 | spliceosomal complex assembly | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 2 | 21 |
GO:0005669 | transcription factor TFIID complex | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 4 | 22 |
GO:0045787 | positive regulation of cell cycle | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 2 | 22 |
GO:0043388 | positive regulation of DNA binding | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 2 | 24 |
GO:0043565 | sequence-specific DNA binding | 1.46e-02 | 1.00e+00 | 3.381 | 2 | 11 | 346 |
GO:0004866 | endopeptidase inhibitor activity | 1.60e-02 | 1.00e+00 | 5.958 | 1 | 3 | 29 |
GO:0005654 | nucleoplasm | 1.77e-02 | 1.00e+00 | 2.322 | 3 | 64 | 1082 |
GO:0060348 | bone development | 1.82e-02 | 1.00e+00 | 5.772 | 1 | 2 | 33 |
GO:0045071 | negative regulation of viral genome replication | 1.87e-02 | 1.00e+00 | 5.729 | 1 | 1 | 34 |
GO:0004221 | ubiquitin thiolesterase activity | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 36 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.10e-02 | 1.00e+00 | 3.105 | 2 | 30 | 419 |
GO:0035019 | somatic stem cell maintenance | 2.20e-02 | 1.00e+00 | 5.494 | 1 | 6 | 40 |
GO:0008168 | methyltransferase activity | 2.25e-02 | 1.00e+00 | 5.459 | 1 | 2 | 41 |
GO:0031124 | mRNA 3'-end processing | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 2 | 42 |
GO:0016579 | protein deubiquitination | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 1 | 42 |
GO:0004402 | histone acetyltransferase activity | 2.36e-02 | 1.00e+00 | 5.390 | 1 | 6 | 43 |
GO:0006369 | termination of RNA polymerase II transcription | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 2 | 45 |
GO:0043525 | positive regulation of neuron apoptotic process | 2.52e-02 | 1.00e+00 | 5.293 | 1 | 4 | 46 |
GO:0004197 | cysteine-type endopeptidase activity | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 1 | 50 |
GO:0006521 | regulation of cellular amino acid metabolic process | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 1 | 50 |
GO:0009611 | response to wounding | 2.85e-02 | 1.00e+00 | 5.116 | 1 | 5 | 52 |
GO:0006406 | mRNA export from nucleus | 3.33e-02 | 1.00e+00 | 4.885 | 1 | 4 | 61 |
GO:0004843 | ubiquitin-specific protease activity | 3.50e-02 | 1.00e+00 | 4.816 | 1 | 1 | 64 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 3.50e-02 | 1.00e+00 | 4.816 | 1 | 1 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 2 | 65 |
GO:0010468 | regulation of gene expression | 3.71e-02 | 1.00e+00 | 4.729 | 1 | 2 | 68 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.82e-02 | 1.00e+00 | 4.687 | 1 | 2 | 70 |
GO:0003729 | mRNA binding | 3.93e-02 | 1.00e+00 | 4.646 | 1 | 4 | 72 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 3.93e-02 | 1.00e+00 | 4.646 | 1 | 1 | 72 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 4.03e-02 | 1.00e+00 | 4.607 | 1 | 4 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.03e-02 | 1.00e+00 | 4.607 | 1 | 2 | 74 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 4.09e-02 | 1.00e+00 | 4.587 | 1 | 1 | 75 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 4.30e-02 | 1.00e+00 | 4.512 | 1 | 2 | 79 |
GO:0009653 | anatomical structure morphogenesis | 4.51e-02 | 1.00e+00 | 4.441 | 1 | 2 | 83 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 4.99e-02 | 1.00e+00 | 4.293 | 1 | 1 | 92 |
GO:0010467 | gene expression | 4.99e-02 | 1.00e+00 | 2.430 | 2 | 45 | 669 |
GO:0005730 | nucleolus | 5.31e-02 | 1.00e+00 | 1.721 | 3 | 66 | 1641 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 5.41e-02 | 1.00e+00 | 2.367 | 2 | 39 | 699 |
GO:0010951 | negative regulation of endopeptidase activity | 5.63e-02 | 1.00e+00 | 4.116 | 1 | 6 | 104 |
GO:0016023 | cytoplasmic membrane-bounded vesicle | 5.68e-02 | 1.00e+00 | 4.102 | 1 | 8 | 105 |
GO:0000209 | protein polyubiquitination | 6.26e-02 | 1.00e+00 | 3.958 | 1 | 3 | 116 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 6.78e-02 | 1.00e+00 | 3.839 | 1 | 5 | 126 |
GO:0045202 | synapse | 7.30e-02 | 1.00e+00 | 3.729 | 1 | 5 | 136 |
GO:0010628 | positive regulation of gene expression | 7.82e-02 | 1.00e+00 | 3.626 | 1 | 7 | 146 |
GO:0000082 | G1/S transition of mitotic cell cycle | 7.97e-02 | 1.00e+00 | 3.597 | 1 | 3 | 149 |
GO:0042981 | regulation of apoptotic process | 8.03e-02 | 1.00e+00 | 3.587 | 1 | 4 | 150 |
GO:0005516 | calmodulin binding | 8.54e-02 | 1.00e+00 | 3.494 | 1 | 2 | 160 |
GO:0000287 | magnesium ion binding | 8.74e-02 | 1.00e+00 | 3.459 | 1 | 4 | 164 |
GO:0000398 | mRNA splicing, via spliceosome | 8.74e-02 | 1.00e+00 | 3.459 | 1 | 15 | 164 |
GO:0044212 | transcription regulatory region DNA binding | 8.95e-02 | 1.00e+00 | 3.424 | 1 | 17 | 168 |
GO:0034641 | cellular nitrogen compound metabolic process | 9.10e-02 | 1.00e+00 | 3.398 | 1 | 2 | 171 |
GO:0005667 | transcription factor complex | 9.31e-02 | 1.00e+00 | 3.365 | 1 | 17 | 175 |
GO:0031625 | ubiquitin protein ligase binding | 9.46e-02 | 1.00e+00 | 3.340 | 1 | 5 | 178 |
GO:0001525 | angiogenesis | 1.01e-01 | 1.00e+00 | 3.239 | 1 | 7 | 191 |
GO:0006355 | regulation of transcription, DNA-templated | 1.01e-01 | 1.00e+00 | 1.855 | 2 | 43 | 997 |
GO:0005622 | intracellular | 1.09e-01 | 1.00e+00 | 3.123 | 1 | 6 | 207 |
GO:0016071 | mRNA metabolic process | 1.17e-01 | 1.00e+00 | 3.015 | 1 | 8 | 223 |
GO:0003713 | transcription coactivator activity | 1.24e-01 | 1.00e+00 | 2.927 | 1 | 24 | 237 |
GO:0008134 | transcription factor binding | 1.27e-01 | 1.00e+00 | 2.897 | 1 | 18 | 242 |
GO:0016070 | RNA metabolic process | 1.29e-01 | 1.00e+00 | 2.868 | 1 | 8 | 247 |
GO:0070062 | extracellular vesicular exosome | 1.34e-01 | 1.00e+00 | 1.172 | 3 | 57 | 2400 |
GO:0000166 | nucleotide binding | 1.35e-01 | 1.00e+00 | 2.799 | 1 | 13 | 259 |
GO:0003779 | actin binding | 1.38e-01 | 1.00e+00 | 2.761 | 1 | 10 | 266 |
GO:0003677 | DNA binding | 1.42e-01 | 1.00e+00 | 1.566 | 2 | 49 | 1218 |
GO:0030154 | cell differentiation | 1.55e-01 | 1.00e+00 | 2.582 | 1 | 5 | 301 |
GO:0035556 | intracellular signal transduction | 1.56e-01 | 1.00e+00 | 2.573 | 1 | 9 | 303 |
GO:0004674 | protein serine/threonine kinase activity | 1.59e-01 | 1.00e+00 | 2.549 | 1 | 6 | 308 |
GO:0007275 | multicellular organismal development | 1.62e-01 | 1.00e+00 | 2.512 | 1 | 7 | 316 |
GO:0007268 | synaptic transmission | 1.70e-01 | 1.00e+00 | 2.441 | 1 | 5 | 332 |
GO:0003723 | RNA binding | 1.75e-01 | 1.00e+00 | 2.398 | 1 | 18 | 342 |
GO:0005925 | focal adhesion | 1.86e-01 | 1.00e+00 | 2.300 | 1 | 9 | 366 |
GO:0008284 | positive regulation of cell proliferation | 1.93e-01 | 1.00e+00 | 2.239 | 1 | 10 | 382 |
GO:0000278 | mitotic cell cycle | 1.97e-01 | 1.00e+00 | 2.205 | 1 | 15 | 391 |
GO:0009986 | cell surface | 2.02e-01 | 1.00e+00 | 2.165 | 1 | 9 | 402 |
GO:0043066 | negative regulation of apoptotic process | 2.12e-01 | 1.00e+00 | 2.088 | 1 | 16 | 424 |
GO:0005634 | nucleus | 2.24e-01 | 1.00e+00 | 0.662 | 4 | 159 | 4559 |
GO:0006468 | protein phosphorylation | 2.28e-01 | 1.00e+00 | 1.971 | 1 | 10 | 460 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.36e-01 | 1.00e+00 | 1.915 | 1 | 24 | 478 |
GO:0005509 | calcium ion binding | 2.59e-01 | 1.00e+00 | 1.764 | 1 | 11 | 531 |
GO:0016032 | viral process | 2.61e-01 | 1.00e+00 | 1.755 | 1 | 26 | 534 |
GO:0006915 | apoptotic process | 2.69e-01 | 1.00e+00 | 1.700 | 1 | 12 | 555 |
GO:0045087 | innate immune response | 2.87e-01 | 1.00e+00 | 1.597 | 1 | 15 | 596 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.62e-01 | 1.00e+00 | 1.192 | 1 | 41 | 789 |
GO:0005829 | cytosol | 4.15e-01 | 1.00e+00 | 0.531 | 2 | 86 | 2496 |
GO:0005886 | plasma membrane | 4.34e-01 | 1.00e+00 | 0.482 | 2 | 49 | 2582 |
GO:0044281 | small molecule metabolic process | 5.04e-01 | 1.00e+00 | 0.574 | 1 | 20 | 1211 |
GO:0005524 | ATP binding | 5.30e-01 | 1.00e+00 | 0.474 | 1 | 31 | 1298 |
GO:0006351 | transcription, DNA-templated | 5.71e-01 | 1.00e+00 | 0.318 | 1 | 57 | 1446 |
GO:0016020 | membrane | 6.29e-01 | 1.00e+00 | 0.101 | 1 | 46 | 1681 |